Honami Yonezawa
Overview
Explore the profile of Honami Yonezawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katagiri H, Yonezawa H, Shitamura S, Sugawara A, Kawano T, Maemondo M, et al.
Biochem Biophys Res Commun
. 2023 Jan;
645:24-29.
PMID: 36669423
Drug resistance has become a challenge in effective longterm molecular targeted therapy. Longterm non-small cell lung cancer (NSCLC) treatments with the first-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)...
2.
Kitamura G, Nankaku M, Kikuchi T, Nishi H, Tanaka H, Nishikawa T, et al.
Assist Technol
. 2022 Nov;
36(6):446-451.
PMID: 36441850
This study aimed to determine whether the distance of gait training using a hybrid assistive limb (HAL) is related to the improvement of walking independence in patients with acute brain...
3.
Yonezawa H, Ikeda A, Takahashi R, Endo H, Sugawara Y, Goto M, et al.
iScience
. 2022 May;
25(3):103912.
PMID: 35530256
Ivermectin (IVM), an avermectin-derivative anthelmintic, specifically binds to glutamate-gated chloride ion channels (GluCls), causing paralysis in invertebrates. IVM also exhibits other biological activities such as Wnt/β-catenin pathway inhibition in vertebrates...
4.
Hamada R, Kondo T, Harada K, Murao M, Miyasaka J, Yoshida M, et al.
Support Care Cancer
. 2022 Jan;
30(5):4027-4034.
PMID: 35066668
Purpose: Decline in physical function in the early stage after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a major challenge. Exercise tolerance tests, such as the 6-min walk test, are...
5.
Tanaka H, Nankaku M, Kikuchi T, Nishi H, Nishikawa T, Yonezawa H, et al.
J Clin Neurosci
. 2021 Sep;
92:17-21.
PMID: 34509247
Using a robot for gait training in stroke patients has attracted attention for the last several decades. Previous studies reported positive effects of robot rehabilitation on gait function in the...
6.
Nishiya N, Yonezawa H
J Antibiot (Tokyo)
. 2021 Aug;
74(10):651-659.
PMID: 34381189
Soil microorganisms are rich sources of bioactive natural products. Interspecies interactions are the cues of their production and refine biological activities. These interactions in natural environments include the interplay between...
7.
Murao M, Hamada R, Kondo T, Miyasaka J, Yoshida M, Yonezawa H, et al.
Support Care Cancer
. 2021 Jun;
29(12):7569-7576.
PMID: 34120260
Purpose: The purpose of this study was to clarify the independent factors related to patient-reported physical functioning (PF) scores at discharge of patients who underwent allogeneic hematopoietic stem cell transplantation...
8.
Hamada R, Arai Y, Kondo T, Harada K, Murao M, Miyasaka J, et al.
Sci Rep
. 2021 Mar;
11(1):7190.
PMID: 33785825
As the proportion of long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is on the rise, it is essential to consider the significance of quality of life (QOL), including...
9.
Nishiya N, Oku Y, Ishikawa C, Fukuda T, Dan S, Mashima T, et al.
Cancer Sci
. 2021 Feb;
112(5):1963-1974.
PMID: 33544933
The emergence of acquired resistance is a major concern associated with molecularly targeted kinase inhibitors. The C797S mutation in the epidermal growth factor receptor (EGFR) confers resistance to osimertinib, a...
10.
Yonezawa H, Sugawara A, Sakyo T, Uehara Y, Kawano T, Nishiya N
Biochem Biophys Res Commun
. 2020 Sep;
532(3):440-445.
PMID: 32891433
Aberrant activation of the canonical Wnt/β-catenin signaling pathway triggers tumorigenesis in various tissues. This study identified an atrarate compound, IMU14, derived from filamentous fungi as an inhibitor of Wnt/β-catenin signaling...